Predict your next investment

INTERNET | Internet Software & Services / Health & Wellness

See what CB Insights has to offer

Founded Year




Total Raised


Date of IPO


Market Cap


Stock Price




About Progyny

Progyny (NASDAQ: PGNY) is a fertility benefits company that combines service, science, technology, and data to provide fertility solutions for self-insured employers. Progyny's approach offers members a comprehensive value-based treatment plan that is based on medical science and technology. The benefit plans are designed to improve outcomes, shorten time to pregnancy, and reduce total fertility-related costs.

Progyny Headquarter Location

1359 Broadway 2nd Floor

New York, New York, 10018,

United States


Latest Progyny News

Progyny, Inc. to Present at the 40th Annual J.P. Morgan Healthcare Conference

Jan 5, 2022

New York, New York, UNITED STATES NEW YORK, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that Pete Anevski, Progyny’s Chief Executive Officer, will present at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 at 8:15 A.M. Eastern Time. Following the presentation, Michael Sturmer, Progyny’s President, and Mark Livingston, Progyny’s Chief Financial Officer, will join Mr. Anevski for a breakout session. A live audiocast and replay of both the presentation and the breakout session will be available from the Events and Presentations section of Progyny’s website at . About Progyny Progyny (Nasdaq: PGNY) is a leading fertility benefits management company in the US. We are redefining fertility and family building benefits, proving that a comprehensive and inclusive fertility solution can simultaneously benefit employers, patients, and physicians. Our benefits solution empowers patients with education and guidance from a dedicated Patient Care Advocate (PCA), provides access to a premier network of fertility specialists using the latest science and technologies, reduces healthcare costs for the nation’s leading employers, and drives optimal clinical outcomes. We envision a world where anyone who wants to have a child can do so. Headquartered in New York City, Progyny has been recognized for its leadership and growth by CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Financial Times, INC. 5000, and Crain’s Fast 50 for NYC. For more information, visit . For Further Information, Please Contact: Investors:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Progyny

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Progyny in 2 CB Insights research briefs, most recently on May 12, 2021.

Expert Collections containing Progyny

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Progyny is included in 3 Expert Collections, including Women's Health & Wellness.


Women's Health & Wellness

1,445 items

Startups focused on providing products and services catering to women's health and wellbeing.


Health Plans & Benefits Management

701 items

Companies developing or offering digital platforms and services, including online insurance marketplaces, data analytics for claims adjustment, benefits administration, and payments systems, that help make private health insurance more affordable, navigable, or transparent.


Digital Health

12,259 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Progyny Patents

Progyny has filed 7 patents.

patents chart

Application Date

Grant Date


Related Topics




Developmental biology, Statistical classification, Classification algorithms, Embryology, Stem cells


Application Date


Grant Date



Related Topics

Developmental biology, Statistical classification, Classification algorithms, Embryology, Stem cells



Progyny Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Progyny Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.